These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1540778)

  • 1. Fluvoxamine withdrawal syndrome.
    Szabadi E
    Br J Psychiatry; 1992 Feb; 160():283-4. PubMed ID: 1540778
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluvoxamine-associated mania/hypomania in patients with obsessive-compulsive disorder.
    Jefferson JW; Greist JH; Perse TL; Rosenfeld R
    J Clin Psychopharmacol; 1991 Dec; 11(6):391-2. PubMed ID: 1770160
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-induced mania.
    Mundo E; Ronchi P; Bellodi L
    Hosp Community Psychiatry; 1993 Jul; 44(7):689-90. PubMed ID: 8354514
    [No Abstract]   [Full Text] [Related]  

  • 4. Manic-switch induced by fluvoxamine in abstinent pure methamphetamine abusers.
    Won M; Minabe Y; Sekine Y; Takei N; Kondo N; Mori N
    J Psychiatry Neurosci; 2003 Mar; 28(2):134-5. PubMed ID: 12670131
    [No Abstract]   [Full Text] [Related]  

  • 5. The Osler's view: Treating comorbid bipolar disorder and obsessive-compulsive disorder.
    Amerio A; Tonna M; Odone A; Ghaemi SN
    Aust N Z J Psychiatry; 2017 Sep; 51(9):944-945. PubMed ID: 28747073
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there a serotonergic withdrawal syndrome?
    Mallya G; White K; Gunderson C
    Biol Psychiatry; 1993 Jun 1-15; 33(11-12):851-2. PubMed ID: 8373925
    [No Abstract]   [Full Text] [Related]  

  • 7. Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder.
    Fennig S; Fennig SN; Pato M; Weitzman A
    Br J Psychiatry; 1994 Jun; 164(6):839-41. PubMed ID: 7952995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral side effects in obsessive-compulsive patients treated with fluvoxamine: a clinical description.
    Diaferia G; Mundo E; Bianchi Y; Ronchi P
    J Clin Psychopharmacol; 1994 Feb; 14(1):78-9. PubMed ID: 8151009
    [No Abstract]   [Full Text] [Related]  

  • 9. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium discontinuation during pregnancy.
    Rifkin A
    Am J Psychiatry; 2001 Oct; 158(10):1741-2. PubMed ID: 11579024
    [No Abstract]   [Full Text] [Related]  

  • 11. Serotonin syndrome from fluvoxamine and buspirone.
    Baetz M; Malcolm D
    Can J Psychiatry; 1995 Sep; 40(7):428-9. PubMed ID: 8548727
    [No Abstract]   [Full Text] [Related]  

  • 12. Dystonic reaction associated with fluvoxamine.
    George MS; Trimble MR
    J Clin Psychopharmacol; 1993 Jun; 13(3):220-1. PubMed ID: 8354740
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvoxamine: safety profile in extensive post-marketing surveillance.
    Buchberger R; Wagner W
    Pharmacopsychiatry; 2002 May; 35(3):101-8. PubMed ID: 12107854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvoxamine-associated manic behavior: a case series.
    Dorevitch A; Frankel Y; Bar-Halperin A; Aronzon R; Zilberman L
    Ann Pharmacother; 1993 Dec; 27(12):1455-7. PubMed ID: 8305775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant-induced mania in obsessive-compulsive disorder.
    Vieta E; Bernardo M
    Am J Psychiatry; 1992 Sep; 149(9):1282-3. PubMed ID: 1503154
    [No Abstract]   [Full Text] [Related]  

  • 17. Serotonin syndrome-like symptoms in a patient with obsessive-compulsive disorder, following inappropriate increase in fluvoxamine dosage.
    Lenzi A; Raffaelli S; Marazziti D
    Pharmacopsychiatry; 1993 May; 26(3):100-1. PubMed ID: 8415895
    [No Abstract]   [Full Text] [Related]  

  • 18. A seizure, and electroencephalographic signs of a lowered seizure threshold, associated with fluvoxamine treatment of obsessive-compulsive disorder.
    Trabert W; Hohagen F; Winkelmann G; Berger M
    Pharmacopsychiatry; 1995 May; 28(3):95-7. PubMed ID: 7568372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluvoxamine treatment of body dysmorphic disorder.
    Hollander E; Cohen L; Simeon D; Rosen J; DeCaria C; Stein DJ
    J Clin Psychopharmacol; 1994 Feb; 14(1):75-7. PubMed ID: 8151008
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluvoxamine for obsessive-compulsive disorder.
    Med Lett Drugs Ther; 1995 Feb; 37(942):13-4. PubMed ID: 7845314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.